Surveillance study of the susceptibility of Haemophilus influenzae to various antibacterial agents in Europe and Canada

Current Medical Research and Opinion

Volumn 24, Issue 10, 2008, Pages 2853-2861

  Jansen, W T M ^a   Verel, A ^a   Beitsma, M ^a   Verhoef, J ^a   Milatovic, D ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Antibacterial resistance; Cephalosporins; Haemophilus influenzae; Macrolides; Penicillins; Quinolones

Indexed keywords

ALANINE; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ASPARAGINE; AZITHROMYCIN; BETA LACTAMASE; CEFACLOR; CEFIXIME; CEFPODOXIME; CEFUROXIME; LEVOFLOXACIN; LYSINE; MOXIFLOXACIN; PENICILLIN BINDING PROTEIN; PENICILLIN BINDING PROTEIN 3B; TELITHROMYCIN; THREONINE; UNCLASSIFIED DRUG; VALINE;

AMINO ACID SUBSTITUTION; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BROTH DILUTION; CANADA; CONTROLLED STUDY; ENZYME SYNTHESIS; EUROPE; GENE MUTATION; GENE SEQUENCE; HAEMOPHILUS INFLUENZAE; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PREVALENCE; RESPIRATORY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; CANADA; DRUG RESISTANCE, BACTERIAL; EUROPE; GUIDELINES AS TOPIC; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HUMANS; MICROBIAL SENSITIVITY TESTS; RESPIRATORY TRACT INFECTIONS;

EID: 55549130496     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/03007990802381505     Document Type: Article

References (17)

1. Block SL, Hedrick J, Harrison CJ, et al. Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of otitis media. Pediatr Infect Dis J 2004;23:829-33
2. Brook I, Foote PA, Hausfeld JN. Frequency of recovery of pathogens causing acute maxillary sinusitis in adults before and after introduction of vaccination of children with the 7-valent pneumococcal vaccine. J Med Microbiol 2006; 55:943-6
3. Brook I, Gober AE. Frequency of recovery of pathogens from the nasopharynx of children with acute maxillary sinusitis before and after the introduction of vaccination with the 7-valent pneumococcal vaccine. Int J Pediatr Otorhinolaryngol 2007; 71:575-9
4. Pichichero ME. Pathogen shifts and changing cure rates for otitis media and tonsillopharyngitis. Clin Pediatr (Phila) 2006;6:493-502
5. Improved vaccines availability as of April 2005 released by Public Health Agency of Canada. Available from http://www.phac-aspc.gc.ca/ media/nr-rp/2005/2005_14bk2-eng.php [last accessed 7 July 2008]
6. Bell SM, Plowman D. Mechanisms of ampicillin resistance in Haemophilus influenzae with four methods and eight media. Antimicrob Agents Chemother 1980;45:1585-8
7. Karlowsky JA, Critchley IA, Blosser-Middleton RS, et al. Antimicrobial surveillance of Haemophilus influenzae in the United States during 2000-2001 leads to detection of clonal dissemination of a β-lactamase-negative and ampicillin resistant strain. J Clin Microbiol 2002;40:1063-4
8. Mendelman PM, Chaffin DO, Stull TL, et al. Characterization of non-β-lactamase-mediated ampicillin resistance in Haemophilus influenzae. Antimicrob Agents Chemother 1984; 26:235-44
9. Clairoux N, Picard M, Brochu A, et al. Molecular basis of the non-β-lactamase-mediated resistance to β-lactam antibiotics in strains of Haemophilus influenzae isolated in Canada. Antimicrob Agents Chemother 1992;36:1504-13
10. Dabernat H, Delmas C, Seguy M, et al. Diversity of β-lactam resistance-conferring amino acid substitutions in penicillin-binding protein 3 of Haemophilus influenzae. Antimicrob Agents Chemother 2002;46:2208-18
11. Jacobs MR, Felmingham D, Appelbaum P. Grüneberg N and the Alexander Project Group. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. J Antimicrob Chemother 2003;52:229-46
12. Hoban D, Felmingham D. The PROTEKT surveillance study: antimicrobial susceptibility of Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections. J Antimicrob Chemother 2002;50 (Suppl Sl):49-59
13. Doern GV, Brueggeman AB, Pierce G, et al. Antibiotic resistance among clinical isolates of Haemophilus influenzae: mechanism and clinical importance and consequences for therapy. Eur J Pediatr 1997;150:534-46
14. Fluit AC, Florijn A, Verhoef J, et al., Susceptibility of European β-lactamase-positive and negative Haemophilus influenzae isolates from the periods 1997/1998 and 2002/2003. J Antimicrob Chemother 2005;56:133-8
15. Jansen WT, Verel A, Beitsma M, et al. Longitudinal European surveillance study of antibiotic resistance of Haemophilus influenzae. J Antimicrob Chemother 2006;58:873-7
16. Ubukata K, Shibasaki Y, Yamamoto K, et al. Association of amino acid substitutions in penicillin binding protein 3 with β-lactam resistance in β-lactamase-negative ampicillin-resistant Haemophilus influenzae. Antimicrob Agents Chemother 2001;45:1693-9
17. Lopalco PL, Editorial team. Use of 7-valent pneumococcal conjugate vaccine in EU. Euro Surveill 2006;11:3092. Available from http://www.eurosurveillance.org/ViewArticle.aspx? Articleld=3092 [last accessed 7 July 2008]